1-5 of 5
Yiling Yu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Biomarker Analysis of Zanubrutinib and Tislelizumab Combination Therapy in Patients with Relapsed/Refractory B-Cell Malignancies

Jiaoyan Lyu, Xiaopeng Ma, Ruiqi Huang, Liyun Zhao, Yiling Yu, Oscar Puig, Yang Liu, James Hilger
Journal: Blood
Blood (2022) 140 (Supplement 1): 3521–3522.
https://doi.org/10.1182/blood-2022-168474
Published: 2022
Journal Articles

Zanubrutinib in relapsed/refractory mantle cell lymphoma: long-term efficacy and safety results from a phase 2 study

Clinical Trials & Observations
Yuqin Song, Keshu Zhou, Dehui Zou, Jianfeng Zhou, Jianda Hu, Haiyan Yang, Huilai Zhang, Jie Ji, Wei Xu, Jie Jin, Fangfang Lv, Ru Feng, Sujun Gao, Haiyi Guo, Lei Zhou, Jane Huang, William Novotny, Pil Kim, Yiling Yu, Binghao Wu, Jun Zhu
Journal: Blood
Blood (2022) 139 (21): 3148–3158.
https://doi.org/10.1182/blood.2021014162
Published: 2022
Includes: Supplemental data
Journal Articles

Zanubrutinib for the treatment of patients with Waldenström macroglobulinemia: 3 years of follow-up

Clinical Trials & Observations
Judith Trotman, Stephen Opat, David Gottlieb, David Simpson, Paula Marlton, Gavin Cull, Javier Munoz, Alessandra Tedeschi, Andrew W. Roberts, John F. Seymour, Siminder Kaur Atwal, Yiling Yu, William Novotny, Eric Holmgren, Ziwen Tan, James D. Hilger, Jane Huang, Constantine S. Tam
Journal: Blood
Blood (2020) 136 (18): 2027–2037.
https://doi.org/10.1182/blood.2020006449
Published: 2020
Includes: Supplemental data
Journal Articles

Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL

Clinical Trials & Observations
Constantine S. Tam, Judith Trotman, Stephen Opat, Jan A. Burger, Gavin Cull, David Gottlieb, Rosemary Harrup, Patrick B. Johnston, Paula Marlton, Javier Munoz, John F. Seymour, David Simpson, Alessandra Tedeschi, Rebecca Elstrom, Yiling Yu, Zhiyu Tang, Lynn Han, Jane Huang, William Novotny, Lai Wang, Andrew W. Roberts
Journal: Blood
Blood (2019) 134 (11): 851–859.
https://doi.org/10.1182/blood.2019001160
Published: 2019
Includes: Supplemental data
Journal Articles

Daratumumab Efficiently Targets NK/T Cell Lymphoma with High CD38 Expression

Nurulhuda Mustafa, PhD, Huey Fang Adina Nee, BSc, Xue Ting Jeannie Lee, BSc, Wei Jin, PhD, Yiling Yu, PhD, Yingnan Chen, PhD, Jennifer Yang, PhD, Wee Joo Chng, MB ChB, MRCP, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2814.
https://doi.org/10.1182/blood.V130.Suppl_1.2814.2814
Published: 2017